SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,089.74 |
| Enterprise Value ($M) | 2,101.38 |
| Book Value ($M) | 234.28 |
| Book Value / Share | 7.26 |
| Price / Book | 4.65 |
| NCAV ($M) | -982.07 |
| NCAV / Share | -30.45 |
| Price / NCAV | -1.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.97 |
| Current Ratio | 1.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 418.81 |
| Assets | 1,635.15 |
| Liabilities | 1,400.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rubric Capital Management LP | 3.88 | -54.68 | |
| 13G | Principal Global Investors | 5.42 | ||
| 13G/A | Eventide Asset Management, Llc | 8.07 | 0.03 | |
| 13G/A | Vanguard Group Inc | 7.09 | 4.74 | |
| 13G/A | BlackRock, Inc. | 17.70 | 0.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES | ||
| UNITED STATES | ||
| UNITED STATES | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 60,688 | 229,061 | 26.49 | |
| 90,095 | 321,477 | 28.03 | |
| 131,785 | 591,648 | 22.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGEM – Cullinan Therapeutics, Inc. | CGON – CG Oncology, Inc. |
| COGT – Cogent Biosciences, Inc. | CPIX – Cumberland Pharmaceuticals Inc. |
| CRBU – Caribou Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io